HIV infection, antiretroviral therapy, and hepatic function. Emerging epidemiological, pathogenetic, and clinical issues, and their consequences on disease management.
Manfredi
Roberto
R
D044966:Anti-Retroviral Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D056486:Chemical and Drug Induced Liver Injury; D015658:HIV Infections / Q000188:drug therapy / Q000503:physiopathology*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D006505:Hepatitis / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008099:Liver / Q000503:physiopathology*; D008107:Liver Diseases / Q000503:physiopathology; D008930:Mitochondria, Liver / Q000502:physiology; D009894:Opportunistic Infections / Q000209:etiology / Q000503:physiopathology; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects
D044966:Anti-Retroviral Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors